Publications
5891 Results
- Journal / Conference
- European Urology 65(2):372-377;
- Year
- 2014
- Research Committee(s)
- Genitourinary
- PMID
- PMID23850254
- PMC
- not available
- Study Number(s)
- 30904
Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904
- Journal / Conference
- Journal of Clinical Oncology 32(suppl 4; abstr 295); ASCO Genitourinary Cancers Symposium (Jan 30-Feb 1, 2014, San Francisco , poster
- Year
- 2014
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1011
Pre-randomization factors and utilization of neoadjuvant chemotherapy in a clinical trial of extended vs. standard pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer
- Journal / Conference
- Journal of Clinical Oncology 32(suppl 4; abstr297); ASCO Genitourinary Cancer Symposium, poster presentation;
- Year
- 2014
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
Optimizing a risk stratification for local-regional failure after radical cystectomy using the SWOG 8710 cohort
- Journal / Conference
- British Journal of Cancer 111(6):1241-1248;
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID25117820
- PMC
- PMC4453857
- Study Number(s)
- CTSU/E2100
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
- Journal / Conference
- Journal of the National Cancer Institute 106(3):djt456;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID24563519
- PMC
- PMC3975165
- Study Number(s)
- S0000
Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk
- Journal / Conference
- Cancer Epidemiology Biomarkers & Prevention 23(8):1494-1504;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID24732629
- PMC
- PMC4119495
- Study Number(s)
- S0000
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial
- Journal / Conference
- British Journal of Haematology May;165(4):504-509;
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24579885
- PMC
- PMC4209396
- Study Number(s)
- S0910
SWOG S0910: A phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukemia
- Journal / Conference
- Cancer Epidemiology, Biomarkers & Prevention 23(8):1484-1493;
- Year
- 2014
- Research Committee(s)
- Cancer Control
- PMID
- PMID25085836
- PMC
- PMC4120235
- Study Number(s)
- SWOG-9217
Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- American Urological Association Annual Meeting (May 16-21, 2014 Orlando, FL), abst. MP69-12; moderated poster session;
- Year
- 2014
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Added value of genetic risk score to the Prostate Cancer Prevention Trial (PCPT) risk calculator: findings from the PCPT study
- Journal / Conference
- Cancer Prevention Research 7(9):950-957;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID24894197
- PMC
- PMC4154984
- Study Number(s)
- S0000